Peter L. Wehrly

Peter L. Wehrly is a seasoned leader in the medical device and biotech industries and brings extensive leadership experience to VIVEX Biologics. As CEO, Mr. Wehrly is responsible for delivering consistent top-line growth and operational efficiencies across the organization.

Prior to joining VIVEX Biologics in 2019, Mr. Wehrly served as CEO and Chairman of the Board for Synaptive Medical, a Toronto-based company that focuses on innovative technology and medical devices for the neuro-cranial and spinal markets. He also held several senior leadership positions with Medtronic, Inc., including Senior Vice President, President of Spinal & Biologics, and President of Medtronic Sofamor Danek. He also directed global business in Western Europe, Japan, Canada, Australia and New Zealand as Group President for Covidien.

During his 17 years with DePuy Orthopedics, a Johnson & Johnson company, Mr. Wehrly was able to leverage his leadership abilities into various managerial roles of increasing responsibilities, including Vice President of Sales & Marketing and President of DePuy OrthoTech. He has also served in numerous board positions at for-profit and not-for-profit organizations.

Mr. Wehrly holds a Bachelor of Science in Management degree from Ball State University and has completed several advanced management programs, including one at the IMD Internal School of Management in Lausanne, Switzerland.